> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Approves Medtronic Evolut FX+
- URL: https://www.fdaweb.com/fda-approves-medtronic-evolut-fx/
- Published: 2024-03-27T12:00:00.000Z
- Updated: 2026-09-14T14:26:38.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5156650

FDA has approved the Medtronic Evolut FX+ transcatheter aortic valve replacement system to treat symptomatic severe aortic stenosis. The company [says](https://news.medtronic.com/2024-03-27-Medtronic-announces-FDA-approval-of-newest-generation-Evolut-TAVR-system-for-treatment-of-symptomatic-severe-aortic-stenosis?ref=fdaweb.com) the latest Evolut system maintains the valve performance benefits of the legacy platform and is designed to facilitate coronary access. Medtronic says it expects a full product launch in the summer of 2024.